The science has proven that gene therapies are effective treatments, and they have given hope to patients and their families ...

High manufacturing costs limit access to cell and gene therapies and make it harder to bring new products to market, according to VIVEbiotech CEO, Jon Alberdi, who says cheaper production ...

Future Market Insights (FMI) has unveiled a groundbreaking forecast for the global cell and gene therapy manufacturing market, predicting extraordinary growth over the next decade. The latest report ...

Joe DePinto, MBA, discussed the findings of the McKesson 2024 Cell and Gene Therapy Report, providing insight into the ...

Cell Therapy and Gene Therapy CDMO Market is Segmented by Type (Cell Therapy, Gene Therapy), by Application (Clinical Stage Projects, Commercialization ...

CellFE®, a leader in non-viral gene editing technology, and Syenex, a pioneer in enveloped delivery vectors, have announced ...

Researchers have discovered a three-drug combination that enhances the generation of CAR-T cells, a type of cancer immunotherapy, and could improve CAR-T cell production for clinical treatments. The ...

About 100 days into the CEO role at Kyverna Therapeutics, Warner Biddle has determined the strategic priorities for the ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Opens Path to Accessible Cell Therapies Through Increased Throughput and Decreased Manufacturing Costs PARIS, Jan. 9, 2025 /PRNewswire/ -- Astraveus SAS ("Astraveus" or the "Company"), ...

Genenta Science has enhanced its collaboration with AGC Biologics by amending their Development and Master Services Agreement to include an exclusive GMP suite in Milan for manufacturing its cell ...